Stock Events

Staar Surgical 

€28.23
4
-€0.53-1.84% Today

Statistics

Day High
28.23
Day Low
28.23
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
1.63B
P/E Ratio
100.27
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0.01
0.13
0.24
0.36
Expected EPS
0.1690372285
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SR3.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

45Average Price Target
The highest estimate is €55.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
43%
Hold
43%
Sell
14%

About

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Show more...
CEO
Mr. Thomas G. Frinzi
Employees
1056
Country
US
ISIN
US8523123052
WKN
000870353

Listings